Actavis Totowa is recalling all of the generic drugs made at its Falls River, New Jersey manufacturing plant. The recall was prompted by the FDA’s inspection at the facility which revealed that operations did not meet the agency’s standards for good manufacturing practices. Actavis Totowa is asking pharmacies, hospitals and retailers to return the affected prescription medications.
In April, Actavis recalled Digitek tablets because some of the medication contained twice the active ingredient normally found in Digitek. According to the FDA, the Digitek defect could cause serious and even fatal digitalis reactions in users. The FDA deemed the Digitek recall a Class I recall, meaning that the defective Digitek tablets could cause serious health problems or death.
Just days after its U.S. division recalled all of its generic drugs, Icelandic drug maker Actavis Group announced that its CEO is stepping down.
Typical outrageous conduct by a pharmaceutical company.
For more information on pharmaceutical litigation, click HERE. Digitek recall information can be found HERE.
